FDA cleared the LymphaTech Mobile 3D Measuring Tool from Lymphatech, Inc. on Oct 28, 2026 under K261628, a traditional 510(k). The device falls under product code OBH, Monitor, Extracellular Fluid, Lymphedema, Extremity, regulated at 21 CFR 870.2770 as a Class 2 device. The review panel was Cardiovascular.

FDA logged the submission as received on May 15, 2026. The decision came 166 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Lymphatech, Inc. in the last 12 months of the tracker.